Willems, Laurent M. http://orcid.org/0000-0001-8226-1674
van der Goten, Milena
von Podewils, Felix http://orcid.org/0000-0002-3134-8697
Knake, Susanne http://orcid.org/0000-0002-6298-0513
Kovac, Stjepana http://orcid.org/0000-0002-2500-6893
Zöllner, Johann Philipp http://orcid.org/0000-0002-7245-2562
Rosenow, Felix http://orcid.org/0000-0002-3989-7471
Strzelczyk, Adam http://orcid.org/0000-0001-6288-9915
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Accepted: 11 May 2023
First Online: 4 June 2023
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. This study was supported by the State of Hesse under the CEPTER LOEWE Grant for the Center of Personalized Translational Epilepsy Research.
: F. von Podewils reports personal fees from UCB Pharma, Arvelle Therapeutics/Angelini Pharma, Desitin Arzneimittel, Zogenix, Eisai, and GW/Jazz Pharmaceuticals and grants from the State of Mecklenburg-Vorpommern and the Deutsches Zentrum für Luft- und Raumfahrt (DLR). S. Knake reports personal fees and grants from Angelini Pharma, Bial, Desitin Arzneimittel, Epilog, Kanso, UCB Pharma, UNEEG, and Zogenix. S. Kovac reports grants from Biogen and speakers honoraria from Eisai and Jazz Pharmaceuticals. J. P. Zöllner reports personal fees from Jazz Pharmaceuticals. F. Rosenow reports grants and personal fees from Roche Pharma, UCB Pharma, Arvelle Therapeutics, and Desitin Arzneimittel, personal fees from Eisai, GW Pharmaceuticals, Novartis, Medtronic, Cerbomed, Sandoz, BayerVital, and Shire and grants from the European Union, Deutsche Forschungsgemeinschaft, the LOEWE Programme of the State of Hesse, and the Detlev–Wrobel–Fonds for Epilepsy Research. A. Strzelczyk reports personal fees and grants from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Jazz (GW) Pharmaceuticals, Marinus Pharmaceuticals, Medtronic, Takeda, UCB Pharma (Zogenix), and UNEEG. All other authors report no competing interests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed. There is no funding to report.
: This study was approved by the Ethics Advisory Board of Goethe University (Frankfurt am Main, Germany) before its conduction (reference number 19-440).
: Study participation was voluntary. Subjects were only enrolled after written informed consent had been obtained.
: Not applicable.
: The datasets generated and/or analyzed during this study are available from the corresponding author upon reasonable request.
: Not applicable.
: A. Strzelczyk conceived the idea for the initial trial and was responsible for the survey. L.M. Willems developed the idea for this analysis. F. von Podewils, S. Knake, S. Kovac, J. P. Zöllner, F. Rosenow and A. Strzelczyk collected the data. M. van den Goten and L.M. Willems processed the data and performed the statistical analyses. L. M. Willems, M. van den Goten, J.P. Zöllner, and A. Strzelczyk drafted the initial manuscript. All authors wrote, edited, and significantly contributed to the final manuscript. All authors approved the final manuscript for submission.